Miltefosine
Back to searchMolecule Structure
Scientific Name
Miltefosine
Description of the Drug
Miltefosine is an antileishmanial agent used to treat leishmaniasis, a group of disease caused by parasites of the Leishmania type.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09031
http://www.drugbank.ca/drugs/DB09031
Brand Name(s)
Impavido, Miltefosine, Miltex
Company Owner(s)
Knight Therapeutics Usa Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL26215 | ||||||||
| Human Metabolome Database | HMDB0254735 | ||||||||
| DrugBank | DB09031 | ||||||||
| PubChem: Thomson Pharma | 14781695 | ||||||||
| PubChem | 3599 | ||||||||
| BindingDB | 50034220 | ||||||||
| EPA CompTox Dashboard | DTXSID7045942 | ||||||||
| DrugCentral | 1810 | ||||||||
| Brenda | 113621 | 145032 | 31494 | 8615 | 229652 | 113620 | 229653 | 145945 | 49554 |
| ChemicalBook | CB6370752 | ||||||||
| rxnorm | MILTEFOSINE | IMPAVIDO | |||||||
| PubChem: Drugs of the Future | 12014266 | ||||||||
| ChEBI | 75283 |
